Another example of an endogenous peptide derived from proglucagon and exhibiting an anti-obesity effect is glucose-dependent insulinotropic polypeptide (GIP) [9]. The gene discussed is GIP; the disease is obesity due to melanocortin 4 receptor deficiency.